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Abstract
Early diagnosis, accurate staging, and image-guided resection of melanomas remain crucial
clinical objectives for improving patient survival and treatment outcomes. Conventional
techniques cannot meet this demand because of the low sensitivity, low specificity, poor spatial
resolution, shallow penetration, and/or ionizing radiation. Here we overcome such limitations by
combining high-resolution photoacoustic tomography (PAT) with extraordinarily optical
absorbing gold nanocages (AuNCs). When bio-conjugated with [Nle4,D-Phe7]-α-melanocyte-
stimulating hormone, the AuNCs can serve as a novel contrast agent for in vivo molecular PAT of
melanomas with both exquisite sensitivity and high specificity. The bio-conjugated AuNCs
enhanced contrast ~300% more than the control, PEGylated AuNCs. The in vivo PAT
quantification of the amount of AuNCs accumulated in melanomas was further validated with
inductively coupled plasma mass spectrometry (ICP-MS).
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The 10-year survival rate of early-stage cutaneous melanoma patients is very high (~99%),
but the rate drops to 40% after nodal metastases.1,2 Thick melanomas (>4 mm) are typically
associated with a high risk of nodal and distant metastases. Highly sensitive molecular
imaging techniques including positron emission tomography (PET) and optical imaging
have been developed for detecting early-stage melanomas.3–5 However, PET requires on the
use of radio-labeling materials, which can cause potential hazards to patients. Moreover, it
suffers from low spatial resolution and high cost due to the need of additional anatomical
information from magnetic resonance imaging (MRI) and/or X-ray computed tomography
(CT). Since optical imaging uses nonionizing radiation and is cost-effective, it has received
much attention in molecular imaging.6 However, conventional optical imaging tools are
often limited by either shallow penetration depth (<1 mm)7 or poor spatial resolution.8
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Besides early detection, accurate delineation of the margins of a melanoma can significantly
improve surgical removal of the primary tumor. High-frequency ultrasound has been applied
preoperatively for this purpose,9 but it cannot effectively resolve the margins of a melanoma
and does not infiltrate cells. Additionally, accurate staging (describing cancer metastasis,
typically with numbers I to IV) of patients after nodal metastases is important for treatment
planning.10 Again, the current technique based on sentinel lymph node biopsy is ionizing
and intraoperative, and thus poses postoperative complications. These limitations of the
current techniques suggest a strong need for a single, highly sensitive, safe, economical,
noninvasive, and high-resolution imaging technique with nonradioactive contrast agents in
early diagnosis of malignant melanomas, image-guided resection of melanoma boundaries,
and accurate staging of melanoma patients.
PAT is a hybrid biomedical imaging modality that offers both strong optical absorption
contrast and high ultrasonic resolution (Supporting Information).11,12 Since the spatial
resolution beyond one optical transport mean free path (~1 mm) is determined by ultrasonic
parameters, the maximum imaging depth and resolution of PAT are scalable when diffusive
photons are available.13–15 By using a near-infrared (NIR) light, one can greatly increase the
penetration depth of PAT because the optical absorption of hemoglobin and scattering of
tissues are weak in this regime. However, it remains a challenge to assess melanomas using
only morphological and functional PAT based on intrinsic contrasts such as tumor hypoxia
and angiogenesis. Therefore, a tumor-specific, exogenous contrast agent is necessary for the
assessment of early-stage melanomas, image-guided resection, and accurate staging by PAT,
with high sensitivity and specificity. Organic dyes such as IRDye-800 and indocyanine
green have been used as contrast agents for PAT,16–18 but these small molecules tend to
suffer from fast clearance times and relatively small optical absorption cross-sections.
Recently, Au-based nanostructures19,20 and single-walled carbon nanotubes (SWCNTs)21
have been demonstrated as contrast agents for PAT. Despite the impressive results, there is
still ongoing debate on the toxicity of CNTs for in vivo applications.22–24 In contrast, Au-
based nanostructures have been approved by FDA as drug carriers or therapeutic agents for
various phase-I clinical trials (e.g., http://www.cytimmune.com and
http://www.nanospectra.com). AuNCs represent an excellent candidate for serving as a
photoacoustic (PA) contrast agent because of its strong and tunable light absorption in the
NIR region, bio-inertness, easiness of bio-conjugation with a tumor-specific ligand, and the
enhanced permeability and retention effect.25–27
RESULTS
The main objective of this study is to evaluate and quantitatively compare the PA contrast
enhancement on B16 melanomas provided by both active and passive targeting AuNCs. In
these cases, the surface of the AuNCs was derivatized, respectively, with [Nle4, D-Phe7]-α-
melanocyte-stimulating hormone ([Nle4, D-Phe7]-α-MSH-AuNCs) and poly(ethylene
glycol) (PEG-AuNCs).25,28 Figure 1a shows a schematic of the [Nle4, D-Phe7]-α-MSH- and
PEG-AuNCs. The difference between these two AuNCs is the presence of [Nle4, D-Phe7]-α-
MSH at the distal end of PEG chain. [Nle4, D-Phe7]-α-MSH has been shown to strongly
bind to α-MSH receptors over-expressed on melanomas, and have higher resistance to
enzymatic degradation and higher specificity than the conventional α-MSH.29,30 We
focused on AuNCs with an outer edge length of 46 nm and a wall thickness of 7 nm (Fig.
1b). Upon surface modification, the optical resonance peak of the AuNCs was slightly red-
shifted due to minor change in refractive index on the surface (Fig. 1c). The absorption
cross-section of the AuNCs were measured as 1.7×10−14 m2 and the ratio of absorption to
extinction cross-sections was 0.7, confirming that the AuNCs absorb light very strongly
(Supporting Information).26 In a phantom, we could still detect PA signals from the AuNCs
at a particle concentration of 4.5 pM and a signal-to-noise ratio (SNR) of 9 (Fig. 1d and
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Supporting Information). This detection limit corresponds to ~9×10−21 moles of AuNCs per
imaging voxel. From in vitro studies, the two types of AuNCs were shown to have different
binding affinities toward melanomas (Fig. 1e). The cellular uptake of [Nle4, D-Phe7]-α-
MSH-AuNCs was ~3.5 times higher than that of PEG-AuNCs after 6-h (123 ± 11 vs. 35 ±
30, p = 0.0005, and the unit is the number of AuNCs per B16 melanoma cell.) or 24-h
incubation (633 ± 121 vs. 182 ± 10, p = 0.007). Based on the measured sensitivity limit (4.5
pM), ~5,000 AuNCs per imaging voxel are required to be detected by our PAT system.
Figure 2a shows an experimental setup of the PAT system. We used macroscopic (10-MHz
ultrasonic frequency) and microscopic (50-MHz ultrasonic frequency) dark-field PAT
systems to image the melanoma and its surrounding microvasculatures, respectively. We
used a light source at 778 nm for melanoma imaging and a light source at 570 nm for blood
vessel imaging. We first acquired in vivo noninvasive morphological and functional PA
images of mice bearing melanomas using intrinsic contrasts (melanin and hemoglobin). In
Figure 2b, the tumor and tumor-feeding blood vessels are clearly seen in the volumetric
structural PA images (Supporting Information for a movie). We also identified the tumor
hypoxia by mapping the hemoglobin oxygen saturation (SO2) of blood vessels within the
melanoma at two different wavelengths, 564 and 570 nm (Fig. 2c and Supporting Fig. S1 for
SO2 mapping in a normal mouse). The average SO2 value in tumor hypoxic regions (56 ±
4%) was less than that (77 ± 7%) in normal mice skin (p = 0.01 and n = 3 mice for each
group), which is consistent with previously reported results.16
We then performed in vivo molecular PAT of melanomas for two groups of mice: one group
(n = 4) with [Nle4, D-Phe7]-α-MSH-AuNCs and the other group (n = 4) with PEG-AuNCs.
Figure 3, a and e, shows photographs of subcutaneous melanomas in the mice. Prior to
AuNCs injection, two control images were acquired for each group (Fig. 3, b and f) by using
the 10-MHz-macroscopic and 50-MHz-microscopic systems to resolve melanoma and blood
vessels, respectively. Then, 100 μL of either [Nle4, D-Phe7]-α-MSH- or PEG-AuNCs at a
particle concentration of 10 nM was intravenously injected into each mouse via a tail vein.
A series of PA images were obtained up to 6 h post-injection. The differential images of the
melanomas before and after injection (i.e., images after injection minus images before
injection) were overlaid on the images of blood vessels. As shown in Figure 3, b–d and f–h,
the melanomas clearly show difference in PA signal enhancement for the two types of
AuNCs (Supporting Fig. S2 for raw images). The average PA signal (golden color) within
the melanoma at 6 h post-injection of [Nle4, D-Phe7]-α-MSH-AuNCs increased by up to
36% (Fig. 3d), whereas the increase only reached 14% for PEG-AuNCs (Fig. 3h). The
observed PA signal enhancement for PEG-AuNCs correlates well with previous results
based on the PEGylated gold nanoshells.20
We plotted the PA signal enhancement in the melanomas as a function of post-injection time
(Fig. 4a). The trend of the PA signal enhancement over time from the bio-conjugated
AuNCs was significantly different (p = 0.0003) from the control PEG-AuNCs. The PA
signals with [Nle4, D-Phe7]-α-MSH-AuNCs increased steeply in the beginning and then
slowly up to 6 h post-injection. In contrast, those with PEG-AuNCs showed a gradual
increase until 5 h post-injection and then a plateau. At 6 h post-injection, the enhancement
with [Nle4, D-Phe7]-α-MSH-AuNCs (38 ± 6%) was on average 300% times greater than that
with PEG-AuNCs (13 ± 2%) (p < 0.0001). This result demonstrates that the [Nle4, D-Phe7]-
α-MSH-AuNCs had a better chance to be accumulated in the tumors than the PEGAuNCs.
To verify this, we quantified the number of AuNCs accumulated in the excised tumors after
PA imaging (6 h post-injection) using ICP-MS (Fig. 4b). The average number of [Nle4, D-
Phe7]-α-MSH-AuNCs per tumor mass (3.6 ± 1.0 × 108 AuNCs/g) was 360% times (p =
0.02) higher than that of PEG-AuNCs (1.0 ± 1.0 × 108 AuNCs/g), which correlates well
with both in vivo and in vitro results. We also estimated the number of [Nle4, D-Phe7]-α-
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MSH-AuNCs taken up per tumor mass based on the PA imaging data (Supporting
Information). In this case, 38% PA signal increase in the tumors corresponds to 8.0 × 108
AuNCs/g, which is close to the number determined using ICP-MS.
DISCUSSION AND SUMMARY
In summary, we have demonstrated the use of AuNCs as a contrast agent for quantitative
molecular PAT of melanomas in vivo. The PA detection limit (4.5 pM) for AuNCs is >2000
times lower than what was reported for SWCNTs (~10 nM) at peak-absorption optical
wavelengths.31 The injection dosage of AuNCs (10 nM) used in our study is also 3 and 100
times, respectively, lower than those of Au nanorods (30 nM)19 and SWCNTs (1.2 μM)21
used for in vivo molecular PAT. When bio-conjugated with [Nle4,D-Phe7]-α-MSH for active
targeting of AuNC to melanoma, the PA signal enhancement was ~300% times higher than
that for the PEG-AuNCs used for passive targeting, as confirmed by the ICP-MS data.
Furthermore, simultaneous functional PA imaging such as SO2 could also reveal the
physiological states of the melanomas. We currently seek to resolve deep melanomas
(Supporting Fig. S3) and demonstrate more versatile use of AuNCs in PAT. Potentially,
high-resolution 3D morphological and functional PAT, when combined with bio-conjugated
AuNCs, can detect early-stage melanomas and metastatic lymph nodes32, treat the
melanomas using photothermal effect of AuNC (as a therapeutic agent or a carrier for
controlled release of drugs)25,33 and/or image-guided surgical resection, monitor post-
treatment processes, and refine post-tumor treatment plans in clinical applications.
METHODS
Synthesis of AuNCs
The detailed procedures for synthesis of AuNCs can be found in ref (28). Briefly, silver
nitrate was reduced in the presence of poly(vinyl pyrrolidone) (PVP) to form uniform 40-nm
Ag nanocubes through a sulfide-mediated polyol method. We then converted the nanocubes
into AuNCs by adding 9 mL of 0.2 mM HAuCl4 aqueous solution to the Ag nanocubes
dispersed in 1 mg/mL PVP aqueous solution under boiling condition. The AuNCs were then
collected by centrifugation and cleaned by washing with deionized water.
Conjugation of targeting molecules with AuNCs
[Nle4, D-Phe7]-α-MSH-AuNCs were prepared by first dispersing the centrifuged AuNCs
with 1 mL of 1 mM aqueous succinimidyl propionyl PEG disulfide (Mwt.≈5,000, Laysan
Bio, USA) solution. After incubation at room temperature for 8 h, the AuNCs were purified
by repeated centrifugation and washing with deionized water (4 times), and then redispersed
in 1 mL of phosphate buffered saline (PBS, pH=7.4) containing [Nle4, D-Phe7]-α-MSH
(EMD Chemicals, USA). The concentration of the peptide in PBS was 0.5 mg/mL. After
incubation at 7 °C for 12 h, the dispersion was centrifuged and the resultant [Nle4, D-Phe7]-
α-MSH-AuNCs were redispersed in fresh PBS. The dispersion was stored at 7 °C until
future use. PEG-AuNCs were prepared by dispersing AuNCs with 1 mL of 1 mM mPEG-SH
(Mwt.≈5,000, Laysan Bio) at room temperature. After 12 h, the PEG-AuNCs were
harvested by repeated centrifugation and washing with deionized water (2 times), and the
resultant PEG-AuNCs were finally dispersed in PBS and stored at 7 °C until future use.
Multi-scale photoacoustic imaging systems12,15
Figure 2a shows a schematic of the dark-field confocal photoacoustic macroscopic imaging
system. Two types of light sources were used in this study: a Ti:sapphire laser (LT-2211A,
LOTIS TII) pumped by a Q-switched Nd:YAG laser (LS-2137, LOTIS) with 6-ns pulse
duration and 10-Hz pulse repetition rate for macroscopic imaging system, and a tunable dye
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laser (Cobra, Sirah) pumped by a Nd:YLF laser (INNOSLAB, Edgewave) with 7-ns pulse
duration and maximum 3-KHz pulse repetition rate for microscopic imaging system. Both
systems use the same dark-field confocal configuration. Formed by a spherical conical lens
and an optical condenser, the dark-field light illumination was coaxially aligned with the
ultrasound focus in water. Dark-field confocal configuration provides a greater penetration
depth and higher SNR. The light fluences on the skin were less than 6.9 and 12 mJ/cm2 for
macroscopic and microscopic imaging systems, respectively, within the ANSI limit. The PA
signals waves were detected by a single-element ultrasound transducer (5, 10, or 50 MHz).
The 50-MHz ultrasonic transducer yields axial and transverse resolutions of 15 μm and 45
μm, respectively. The maximum penetration depth at the ultrasonic frequency of 50 MHz is
~3 mm in mouse skin.13 The 10-MHz ultrasonic transducer yields axial and transverse
resolutions of 125 μm and 140 μm, respectively. The 5-MHz ultrasonic transducer yields
axial and transverse resolutions of 150 μm and 560 μm, respectively. The maximum
penetration depth at the ultrasonic frequency of 5 MHz along with NIR excitation is ~30 mm
in biological tissues.15 By measuring PA amplitudes according to the arrival times, one-
dimensional depth-resolved images, referred to as A-lines, are acquired. Additional raster
scanning along a transverse direction enables the construction of two-dimensional depth-
resolved images (B-scans), and further scanning along the other traverse direction provides
three-dimensional images of optical absorption heterogeneities in biological tissues. The
acquired three-dimensional raw data can be processed in two forms: a maximum amplitude
projection (MAP) - a projection of the maximum PA amplitude along each A-line onto the
corresponding plane - and a true three-dimensional image using Volview software
(Kitware).
B16 melanoma cell culture
B16 melanoma cell lines (CRL-6322™, B16-F0 mouse melanoma, American Type Culture
Collection, USA) were cultured in DMEM (Sigma), supplemented with 10% fetal bovine
serum (FBS, Sigma). The medium was changed every other day, and the cultures were
incubated at 37 °C in a humidified atmosphere containing 5% CO2. No antibiotics was used.
The cells get passed once a week or so.
In vitro cell studies with AuNCs
We first added the culture medium containing AuNCs (0.01 nM) to the cells (80%
confluence) cultured in a 6-well plate. After 6 and 24 h, we removed the culture medium,
washing with PBS three times, and the cells were treated with 1.4 mL trypsin solution
(0.05%) at 37 °C. The trypsinized cell dispersion was further sonicated in a hot water bath
(60 °C) to completely disrupt the cell membranes. Finally, the AuNCs were dissolved by
successively adding 0.3 mL hydrochloric acid (HCL) and 0.1 mL nitric acid (HNO3) to the
solution. The concentration of Au, determined by ICP-MS (7500 CS, Agilent, USA), was
first converted to the total number of AuNCs taken up by all of the cells in each culture well.
The volume of a single AuNC was measured by TEM, and the mass of one AuNC was
estimated using its density. Next, the total number of AuNCs in one culture well was
calculated by dividing the total mass of AuNCs by the mass of one AuNC. The number of
cells in each well was counted by hematocytometer. Then, we calculated the ratio of the
total number of AuNCs to the total number of cells in each culture well to determine the
number of AuNCs taken up by a single cell.
Animal handling
All in vivo animal experiments were carried out in compliance with the Washington
University Institutional Animal Care and Use Committee. Immunocompetent nude mice
weighing about 30 g were used for the in vivo experiments. B16 melanoma cells (~105 cells)
were subcutaneously inoculated into dorsal part of mice, and PA imaging was performed
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after 2 weeks of tumor growth. The mice were initially anesthetized with a mixture of
Ketamine (85 mg/kg) and Xylazine (15 mg/kg). During PA imaging experiments, anesthesia
was maintained using vaporized isoflurane (1 L/min oxygen and 0.75% isoflurane, Euthanex
Corp.), and vitals were monitored using a pulse oximeter (NONIN Medical INC., 8600V).
The body temperatures of mice were maintained by using a water heating pad. After the
image acquisition, the mice were euthanized by administrating an overdose of pentobarbital,
and the tumors were excised for ICP-MS experiments.
ICP-MS experiments of AuNCs on dissected tumors
The excised tumors were weighed, and the tumors were dissolved completely by adding 9
mL of HCL and 3 mL of HNO3 at 70 °C for 30 min. The solution was diluted with
deionized water. After filtering the solution with 0.45 μm Teflon filter, we determined the
concentration of Au ions and thereby the AuNCs accumulated in the tumors by ICP-MS.
Statistical analysis
All data obtained from the experiments were summarized using means ± standard
deviations. The cellular uptake values from in vitro studies (Fig. 1e) were compared using 2-
factor ANOVA, while the average PA signal enhancement from in vivo studies (Fig. 4a)
were compared using 2-factor ANOVA for repeated measurement data. The differences in
average SO2 values (Fig. 2d) and the number of accumulated AuNCs (Fig. 4b) were
compared using two-group t-tests. Although all data were summarized in the original scales
for easy interpretation, data in Figures 1e and 4b were logarithmically transformed to better
satisfy the normality assumption. All tests were 2-sided with an alpha-level of 0.05
indicating significance. To control the family-wise alpha-level at the designated 0.05 level,
multiple, post-hoc comparisons were performed following ANOVA only if the overall
interaction term was significant.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1.
Schematic, characterization, photoacoustic properties, and cellular uptake of the AuNCs. a,
[Nle4,D-Phe7]-α-MSH-AuNCs (left) and PEG-AuNCs (right). b, A typical transmission
electron microscopy image of the AuNCs. c, UV-vis-NIR spectra of the AuNCs (18 pM)
conjugated with different chemical agents. μe is the extinction coefficient. d, Plot of the PA
amplitude as a function of AuNCs concentration. e, In vitro uptake of [Nle4, D-Phe7]-α-
MSH-AuNCs and PEG-AuNCs by B16 melanoma cells as determined by ICP-MS. Here
Ncell denotes the number of AuNCs per B16 melanoma cell (p = 0.0005 at 6-h and p = 0.007
at 24-h).
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Figure 2.
Experimental setup of the PA imaging system and noninvasive morphological and
functional PA images of B16 melanomas in vivo. a, Photograph of the PA macroscope. The
schematic in the dashed box shows a dark-field, confocal configuration. b, Volumetric
morphological PA image of B16 melanoma (yellow) and its surrounding blood vessels (red).
BV, blood vessels. The melanoma was imaged using the PA macroscope at 778 nm
(ultrasonic frequency: 10 MHz), and the surrounding vasculatures were obtained using a PA
microscope at 570 nm (ultrasonic frequency: 50 MHz). c, PA MAP mapping of hemoglobin
oxygen saturation (SO2) of blood vessels surrounding the melanoma using two optical
wavelengths of 564 and 570 nm. The white dotted line shows the tumor boundary. d,
Statistical analysis of the average SO2 in normal mice skins and tumor hypoxic area. The
average SO2 value in normal mice skins and tumor hypoxic regions are 77±7% and 56±4%
and, respectively (p = 0.01 and n = 3 mice for each group).
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Figure 3.
In vivo noninvasive PA time-course coronal MAP images of B16 melanomas using [Nle4,D-
Phe7]-α-MSH- and PEG-AuNCs. a and e, Photographs of nude mice transplanted with B16
melanomas before injection of (a) [Nle4,D-Phe7]-α-MSH- and (e) PEG-AuNCs. b–d and f–
h, Time-course PA images of the B16 melanomas after intravenous injection with 100 μL of
10-nM (b–d) [Nle4,D-Phe7]-α-MSH- and (f–h) PEG-AuNCs through the tail vein. The
background vasculature images were obtained using the PA microscope at 570 nm
(ultrasonic frequency: 50 MHz) and the melanoma images were obtained using the PA
macroscope at 778 nm (ultrasonic frequency: 10 MHz). Color schemes: red for blood
vessels and yellow for the increase in PA amplitude.
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Figure 4.
Increase in PA amplitude within the melanomas after intravenous injection of AuNCs and
quantification of the AuNCs taken up by the tumors. a, Time-course changes (%) in PA
amplitude after intravenous injection of [Nle4,D-Phe7]-α-MSH- and PEG-AuNCs (n = 4
mice for each group). The PA signals increased up to 38 ± 6% for [Nle4,D-Phe7]-α-MSH-
AuNCs while the maximum signal increase only reached 13 ± 2% for PEG-AuNCs at a
post-injection time of 6 h (p < 0.0001). b, The average number of AuNCs accumulated in the
melanomas dissected at 6 h post-injection for the two types of AuNCs as measured by ICP-
MS. Here Ntumor denotes the number of AuNCs per unit tumor mass (g). The average
number of [Nle4,D-Phe7]-α-MSH-AuNCs per tumor mass (3.6 ± 1.0 × 108 AuNCs/g) was
3.6 times (p = 0.02) that of PEG-AuNCs (1.0 ± 1.0 × 108 AuNCs/g).
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